Osgood, Michael J <br/><br/>
Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.  [electronic resource] 

 -  Journal of vascular surgery  Aug 2016 
 - 471-478 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-6809 
<br/><br/><label>Standard No.: </label>10.1016/j.jvs.2015.02.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzenesulfonates--pharmacology<br/>Cell Line<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Coloring Agents--pharmacology<br/>Humans<br/>Hyperplasia<br/>Jugular Veins--drug effects<br/>Models, Animal<br/>Muscle, Smooth, Vascular--drug effects<br/>Myocytes, Smooth Muscle--drug effects<br/>Neointima<br/>Organ Culture Techniques<br/>Purinergic P2X Receptor Antagonists--pharmacology<br/>Rabbits<br/>Rats<br/>Receptors, Purinergic P2X7--drug effects<br/>Saphenous Vein--drug effects<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tissue and Organ Harvesting--adverse effects